A possible vaccine against meningitis B has shown "encouraging" results in preliminary clinical trials. The MenB vaccine from pharmaceutical giant Novartis was tested on 150 babies in the UK. Thousands of deaths and disabilities are caused globally by meningitis B, but a vaccine is difficult to produce because of the many different strains.
See all
